Clinical Trial Update: Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term Birth [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial comparing atosiban with placebo for late threatened preterm birth was reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Atosiban (atosiban)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Preterm Birth | Phase 4 | Status: COMPLETED